Kazazian Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Kazazian Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$96K	Hold	11,554	–	–	0.13%	51
2019 Q2	$99K	Sell	11,554 -1,500	-11%	-$13.4K	0.12%	61
2019 Q1	$140K	Sell	13,054 -4,500	-26%	-$48.2K	0.19%	54
2018 Q4	$154K	Sell	17,554 -20,036	-53%	-$255K	0.21%	57
2018 Q3	$632K	Hold	37,590	–	–	0.59%	39
2018 Q2	$788K	Buy	37,590 +5,064	+16%	+$93.8K	0.72%	31
2018 Q1	$523K	Hold	32,526	–	–	0.55%	41
2017 Q4	$616K	Buy	+32,526	New	+$589K	0.63%	39

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kazazian Asset Management's SPPI Position: Q3 2019 in Review

Kazazian Asset Management held its Spectrum Pharmaceuticals Inc (SPPI) position steady in Q3 2019 at 11,554 shares worth $96K. The position accounts for 0.13% of the portfolio, ranked #51.

Kazazian Asset Management first reported a position in SPPI in Q4 2017 and has held it in 8 quarters since. The position peaked at $788K in Q2 2018. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Kazazian Asset Management held 11,554 shares of Spectrum Pharmaceuticals Inc worth $96K as of Q3 2019.
Kazazian Asset Management left its Spectrum Pharmaceuticals Inc share count unchanged in Q3 2019.
Spectrum Pharmaceuticals Inc made up 0.13% of Kazazian Asset Management's portfolio in Q3 2019, its #51 holding.
Kazazian Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and has held it in 8 quarters since.
Kazazian Asset Management's Spectrum Pharmaceuticals Inc position peaked at $788K in Q2 2018.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.